Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients. Leukemia 2021 Nov;35(11):3287-3290
Date
04/07/2021Pubmed ID
33820961Pubmed Central ID
PMC8490482DOI
10.1038/s41375-021-01237-xScopus ID
2-s2.0-85103562051 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Miller CR, Huang Y, Ruppert AS, Labanowska J, Jaglowski SM, Maddocks KJ, Rogers KA, Bhat S, Kittai AS, Grever M, Lapalombella R, Abruzzo LV, Heerema NA, Byrd JC, Hertlein EK, Woyach JAAuthor
Samantha M. Jaglowski MD, MPH Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenineAdult
Aged
Aged, 80 and over
Chromosome Aberrations
Chromosomes, Human, Pair 2
Cohort Studies
Female
Follow-Up Studies
Gene Dosage
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Piperidines
Prognosis
Survival Rate
